The knowledge and skills required for the onco-rheumatologist: Study of four-year consultation records of a high-volume cancer centre
Modern Rheumatology · 08.04.2025 · 35 (3) · 402-409
DOI: 10.1093/mr/roae114 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Rheumatology, online erschienen am 19.12.2024. Verfasst von Koichi Takeda und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Onco-Rheumatology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan. Hauptthemen laut MEDLINE: Neoplasms, Rheumatologists, Clinical Competence, Rheumatology. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
Onco-rheumatology, the intersection of oncology and rheumatology, is an emerging field requiring further definition. This study aimed to identify the knowledge and skills essential for rheumatologists in clinical oncology.
Methods
We retrospectively reviewed consultations with the onco-rheumatology department of a high-volume tertiary cancer centre in Japan from January 2020 to December 2023.
Results
We analysed 417 consultations. The most common consultation (229, 55%) was related to immune checkpoint inhibitor-induced immune-related adverse events (irAEs). Of the 238 irAEs in 185 patients, 15% were rheumatic and 85% were nonrheumatic (e.g. hepatobiliary toxicities, colitis). Approximately 25% of nonendocrine irAEs were refractory/relapsing, requiring second-line therapy (e.g. mycophenolate mofetil, biologics, immunoglobulin). In addition to irAE consultations, 137 (33%) consultations were about possible rheumatic diseases. The final diagnosis often related to cancer treatment, such as granulocyte colony-stimulating factor-related aortitis (15 patients, 11%), olaparib-related erythema nodosum (10 patients, 7.3%), and surgical menopause-related arthralgia (10 patients, 7.3%). Five patients (3.6%) were diagnosed with autoinflammatory bone disease mimicking bone tumours.
Conclusions
Onco-rheumatologists are expected to play a central role in the management of a wide range of irAEs, not limited to rheumatic irAEs. They must also manage rheumatologic manifestations during cancer treatment and rheumatic diseases that mimic tumours.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Onco-Rheumatology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
- Department of Infectious Diseases, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
- Department of General Medicine, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
- Department of Onco-Cardiology/Cardiovascular Medicine, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
ORCID-Profile: Koichi Takeda
Zitieren
APA
Takeda, K., & Shiga, T. (2025). The knowledge and skills required for the onco-rheumatologist: Study of four-year consultation records of a high-volume cancer centre. Modern Rheumatology, 35(3), 402-409. https://doi.org/10.1093/mr/roae114
Vancouver
Takeda K, Shiga T. The knowledge and skills required for the onco-rheumatologist: Study of four-year consultation records of a high-volume cancer centre. Modern Rheumatology. 2025;35(3):402-409. doi:10.1093/mr/roae114
BibTeX
@article{Takeda2025,
author = {Takeda, Koichi and Shiga, Taro},
title = {The knowledge and skills required for the onco-rheumatologist: Study of four-year consultation records of a high-volume cancer centre},
journal = {Modern Rheumatology},
year = {2025},
volume = {35},
number = {3},
pages = {402--409},
doi = {10.1093/mr/roae114}
}
EUVIMED